{"id":11997,"date":"2016-02-05T09:29:16","date_gmt":"2016-02-05T09:29:16","guid":{"rendered":"https:\/\/haeaustralasia.org.au\/?p=11997"},"modified":"2017-04-04T08:04:08","modified_gmt":"2017-04-04T08:04:08","slug":"c1-esterase-inhibitor-concentrate-in-australia","status":"publish","type":"post","link":"https:\/\/haeaustralasia.org.au\/c1-esterase-inhibitor-concentrate-in-australia\/","title":{"rendered":"C1 Esterase Inhibitor Concentrate in Australia"},"content":{"rendered":"

On 11 December 2015 the Jurisdictional Blood Committee (JBC) considered recommendations by the Medical Services Advisory Committee (MSAC) in relation to the proposed addition of C1 esterase inhibitor concentrate to the national arrangements for supply and funding of blood products administered by the National Blood Authority (NBA).<\/p>\n

JBC have agreed to the addition of C1 esterase inhibitor concentrate, for the following indications where MSAC considered that cost effectiveness could be established:<\/p>\n